Clinically and pathologically, the ALK-rearranged subtype of NSCLC forms a distinct entity among lung adenocarcinomas, usually characterized by young onset, non- or light-smoking history, poor-differentiation with acinar-predominant structure and with mucin/signet-ring cell pattern on histological analysis [14,15,16]. The gene discussed is ALK; the disease is lung adenocarcinoma.